Device developed to diagnose coronavirus: DRAP

0

ISLAMABAD: Pakistan has locally developed a modern device to diagnose coronavirus within a minute, confirmed CEO Drug Regulatory Authority of Pakistan (DRAP) Dr Asim Rauf on Saturday.
The invention is being regarded as a major breakthrough for Pakistan in its fight against the pandemic. The device has been approved by the DRAP.
According to details, the device is capable of diagnosing the deadly disease within a minute through the lungs. The device has been named Covid Rapid Artificial Intelligence Detection.
Dr Asim said that the device has been purely developed at the domestic level and has been approved under the DRAP Act 2012. He said that the device will be helpful for Pakistan in the war against COVID-19 as it can detect the infection within a minute.
The CEO DRAP said that the device that was developed by National Electronics Complex Pakistan, will be available in the market soon. Only a few countries are using COVID technology, Dr Rauf said and added that Pakistan will export the device to other countries to help them in fighting the pandemic.
Earlier this year, the Drug Regulatory Authority of Pakistan (DRAP) had approved the country’s first-ever locally developed testing kits for coronavirus detection. The kits had been developed by the National University of Sciences and Technology (NUST).
Meanwhile, the medical experts at Dow University of Health Sciences (DUHS), Karachi, are conducting clinical trials of a drug to treat patients suffering from the novel coronavirus.
A research team of the DUHS had announced in the second week of April that they had devised intravenous immunoglobulin (IVIG) with plasma obtained from the blood of patients recovered from Covid-19.
The plasma teeming with antibodies was donated by patients after recovering from the illness. According to doctors, during trials the recovery percentage of the patients in extremely serious condition remained 60 percent, while the recovery percentage of the serious patients reached to 100 percent while they were treated with IVIG.
The research team initially conducted lab tests and animal trials, which were successful. In the next step they initiated clinical trials. “This is a very important breakthrough in the war against Covid-19,” professor Shaukat Ali, the head of the research team had earlier told the media.
The Drug Regulatory Authority of Pakistan (DRAP) has extended its cooperation in the clinical trials of the drug, Dr Shaukat Ali said.
The research work on IVIG was initiated in March this year on the instructions of Professor Muhammad Saeed Qureshi, the vice chanccellor of DUHS and later in the second week of April, the researchers announced breakthrough in the fight against novel coronavirus.
Many countries across the world including Turkey, France and the US are holding clinical trials for plasma therapy or transfusion to fight the novel virus. However, the Pakistani doctor said, the treatment they have devised is safer and more effective than plasma transfusion as it does not carry the undesired components of blood like plasma proteins, potential bacterial and viral pathogens.

Leave A Reply

Your email address will not be published.